# CRP Apheresis in STEMI

Study · id `cardio:ct-nct04939805` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04939805](<https://clinicaltrials.gov/study/NCT04939805>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04939805

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 202 participants.

## Technical summary

Registry record NCT04939805. Randomized; single masking; primary purpose treatment. Start 2021-04-01 (actual); primary completion 2026-01-28 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 202 participants (planned count; ClinicalTrials.gov record NCT04939805, source copy `cardio:ctgov-nct04939805-2026-10-07`, retrieved 2026-10-26)
- Started: 2021-04-01 (actual) (ClinicalTrials.gov record NCT04939805, source copy `cardio:ctgov-nct04939805-2026-10-07`, retrieved 2026-10-26)
- Primary completion: 2026-01-28 (actual) (ClinicalTrials.gov record NCT04939805, source copy `cardio:ctgov-nct04939805-2026-10-07`, retrieved 2026-10-26)
- Completion: 2026-12-15 (anticipated) (ClinicalTrials.gov record NCT04939805, source copy `cardio:ctgov-nct04939805-2026-10-07`, retrieved 2026-10-26)
- Countries: Austria; Germany (ClinicalTrials.gov record NCT04939805, source copy `cardio:ctgov-nct04939805-2026-10-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04939805-2026-10-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: CRP Apheresis in STEMI
- Condition: ST Elevation Myocardial Infarction
- Condition: C-Reactive Protein
- Condition: Apheresis
- Condition: Myocardial Injury
- Intervention (Device): Selective CRP apheresis using the PentraSorb®-CRP system
- Lead sponsor: Medical University Innsbruck
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: Medical University Innsbruck (`cardio:org-medical-university-innsbruck`)

## Provenance

Content hash: d2687b031a0daa5e3fc4bc353f803903c0ce24566c2cb441bfaa84861d09902c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
